The mean nuclear GR imunoreactivity score in the residual cancer cells in the CHT group was significantly higher than that in the NNA (4.83 ± 0.20 vs. 3.35 ± 0.29, respectively, p < 0.001) and NHT groups (4.83 ± 0.20 vs. 3.38 ± 0.37, respectively, p = 0.001, Fig. 4b). The gene discussed is NR3C1; the disease is cancer.